Search results
Experimental drug shows promise in treating cancer linked to asbestos
United Press International via Yahoo News· 3 months agoAn experimental drug called ADI-PEG20 increased average survival of mesothelioma patients by 1.6...
£2.1m cash injection to help researchers detect asbestos cancer earlier
Press Association News via AOL· 1 year agoResearchers studying why it can take decades for exposure to asbestos to develop into a cancer...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 6 hours agoBristol Myers Squibb’s (BMS) blockbuster cancer therapies Opdivo (nivolumab) and Yervoy (ipilimumab)...
Survival Rates Improve with SELLAS's New Treatment for Severe Lung Cancer, Phase 1 Study Shows
Benzinga via Yahoo Finance· 11 months agoSELLAS Life Sciences Group Inc (NASDAQ: SLS) released topline data from a Phase 1 trial of its lead...
Cancer stages, survival rates and what a diagnosis really means
The Telegraph via Yahoo News· 3 months agoThe world is still reeling in shock and sympathy from King Charles’s diagnosis. Understandably, the...
Fewer middle-aged people dying from cancer but cases rise – study
PA Media: Science via Yahoo News· 2 months agoFewer middle-aged people are dying from cancer than at any point in 25 years, though cases are...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 8 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Why NovoCure Stock Is Crashing Today
Motley Fool· 9 months agoShares of NovoCure (NASDAQ: NVCR) were crashing 32.8% lower as of 11:24 a.m. ET on Monday. The sharp sell-off came after the company announced that a...
Here's Why Novocure Stock Dropped 42% in June
Motley Fool· 10 months agoWhat happened Novocure (NASDAQ: NVCR) shares dropped after publishing the results of an important clinical trial. The headlines looked positive at first...
TCR2 Therapeutics Shares Jump After Additional Reponses in Ovarian Cancer, Mesothelioma
Benzinga via Yahoo Finance· 2 years agoTCR2 Therapeutics Inc (NASDAQ: TCRR) has announced topline results from the Phase 1 portion of the...